| 000 | 01121 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250517202024.0 | ||
| 264 | 0 | _c20190520 | |
| 008 | 201905s 0 0 eng d | ||
| 022 | _a1879-6265 | ||
| 024 | 7 |
_a10.1016/j.coviro.2018.01.011 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLindh, Magnus | |
| 245 | 0 | 0 |
_aImpact of integrated viral DNA on the goal to clear hepatitis B surface antigen with different therapeutic strategies. _h[electronic resource] |
| 260 |
_bCurrent opinion in virology _c06 2018 |
||
| 300 |
_a24-31 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAntiviral Agents _xpharmacology |
| 650 | 0 | 4 |
_aDrug Discovery _xtrends |
| 650 | 0 | 4 |
_aGenetic Therapy _xmethods |
| 650 | 0 | 4 |
_aHepatitis B _xdrug therapy |
| 650 | 0 | 4 |
_aHepatitis B virus _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aVirus Integration _xdrug effects |
| 700 | 1 | _aRydell, Gustaf E | |
| 700 | 1 | _aLarsson, Simon B | |
| 773 | 0 |
_tCurrent opinion in virology _gvol. 30 _gp. 24-31 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.coviro.2018.01.011 _zAvailable from publisher's website |
| 999 |
_c28095283 _d28095283 |
||